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EDITORIAL
The quest for the gene responsible for medullary
cystic kidney disease type 1
The publication in February 2001 of the initial se-
quencing and analysis of the human genome (http://www.
nhgri.nih.gov) changed the way we make diagnoses and
practice medicine, but investigators are still searching, in
2004, to identify genes responsible for apparently sim-
ple monogenic diseases. In this issue of Kidney Inerna-
tional, Wolf et al [1] are continuing their quest to iden-
tify the gene in chromosome region 1q21 responsible for
medullary cystic kidney disease type 1 (MCKD1). This
is one of the last monogenic kidney diseases to con-
quer. Genes responsible for other inherited tubuloin-
terstitial nephritis have been found, and nephrologists
are now able to distinguish nephronophthisis from other
hereditary medullary cystic kidney diseases (MCKD)
(Table 1). Four genes (nephrocystin 1, inversin (for-
merly nephrocystin 2), nephrocystin 3, and nephrocystin
4; gene symbols NPHP1, INVS, NPHP3, and NPHP4, re-
spectively) have been identified for autosomal-recessive
juvenile nephronophthisis, and one (uromodulin; gene
symbol UMOD) for the autosomal-dominant condition
of MCKD2. MCKD is usually recognized later in life
and leads to end-stage renal disease around the age of
50 years.
The cell biology of these newly identified proteins re-
sponsible, when dysfunctional, for juvenile nephronoph-
thisis is interesting because cilial dysfunction may under-
lie all forms of cystic disease: adult autosomal-dominant
polycystic kidney disease type 1 and type 2 and also ju-
venile nephronophthisis [2, 3].
MCKD2 and some familial juvenile hyperuricemic
nephropathy (FJHN) are allelic disorders [4]. FJHN
is an autosomal-dominant disease with hyperuricemia,
gout, and renal failure secondary to mutations in the
UMOD gene coding for the Tamm-Horsfall glycopro-
tein, also referred to as uromodulin. Like MCKD, the
renal histopathologic findings include chronic tubuloin-
terstitial nephropathy with focal areas of interstitial fi-
brosis and inflammatory cell infiltration, thickening of
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the tubular basement membrane, and glomerulosclero-
sis. All these pathologic findings are nonspecific and are
also shared by nephronophthisis.
Wolf et al have narrowed the candidate interval for
the MCKD1 gene to a 2.1-Mb interval based on a re-
combinant event in a Belgian kindred, and possibly to
a smaller interval (<650 kb) based on a shared hap-
lotype among families from the United States, United
Kingdom, and Germany, and the assumption that af-
fected individuals in these families have inherited copies
of the same disease-causing mutation from a common
ancestor [5]. Perhaps the interval could be reduced by
typing additional microsatellites or single nucleotide
polymorphisms, but the chance of finding further key
recombinants is slim. If there are no obvious candidate
genes based on known gene function or bioinformatic
analyses, then brute force DNA sequencing is the remain-
ing option.
The molecular identification of all the genes respon-
sible for hereditary MCKD in children and adults is
of considerable importance for the long-term objec-
tive of prevention of renal failure. For example, in se-
lected geographic areas, MCKD1 is the leading cause
of end-stage renal failure, accounting for 40% of all
cases [6]. The identification of the gene and the mu-
tation in each family will allow precise identification
of potential related donor candidates. Nephronophthi-
sis is also the most common genetic cause of chronic
renal failure in children. It is likely that the exact preva-
lence of these diseases in the general end-stage renal
failure population is not precisely known and/or under-
estimated. The identification of genes and mechanisms
underlying these chronic diseases could lead to phar-
macologic treatment as recently described in a mouse
model of autosomal-dominant polycystic kidney disease
[7].
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Table 1. Inherited tubulointerstitial nephritis: The nephronophthisis-MCKD complex
Disorder Nephronophthisis Medullary cystic kidney disease
Common features
Clinical symptoms .....polyuria, polydipsia, anemia.................................................
Macroscopic findings .....cysts at the corticomedullary border...................................
Histology .....tubular atrophy, interstitial fibrosis, cell infiltration..........
Differences
Mode of inheritance Autosomal recessive Autosomal dominant
Age at end-stage renal disease Childhood to adolescence Adulthood (3rd to 5th decade of life or even later, but
in some disease may be present in childhood)
Extrarenal manifestations Retinal abnormalities (Senior-Loken
syndrome and oculomotor apraxia,
Cogan type)
Gout and hyperuricemia (familial juvenile
hyperuricemic nephropathy)
DNA mutation analysis NPHP1, INVS, NPHP3, NPHP4 UMOD
REFERENCES
1. WOLF MTF, VAN VLEM B, HENNIES HC, et al: Telomeric refinement
of the MCKD1 locus on chromosome 1q21. Kidney Int 66:580–585,
2004
2. WATNICK T, GERMINO G: From cilia to cyst. Nat Genet 34:355–356,
2003
3. BOUCHER C, SANDFORD R: Autosomal dominant polycystic kidney
disease (ADPKD, MIM 173900, PKD1 and PKD2 genes, protein
products known as polycystin-1 and polycystin-2). Eur J Hum Genet
12:347–354, 2004
4. KUDO E, KAMATANI N, TEZUKA O, et al: Familial juvenile hyper-
uricemic nephropathy: Detection of mutations in the uromodulin
gene in five Japanese families. Kidney Int 65:1589–1597, 2004
5. WOLF MT, KARLE SM, SCHWARZ S, et al: Refinement of the critical re-
gion for MCKD1 by detection of transcontinental haplotype sharing.
Kidney Int 64:788–792, 2003
6. STAVROU C, DELTAS CC, CHRISTOPHIDES TC, PIERIDES A: Outcome
of kidney transplantation in autosomal dominant medullary cys-
tic kidney disease type 1. Nephrol Dial Transplant 18:2165–2169,
2003
7. TORRES VE, WANG X, QIAN Q, et al: Effective treatment of an orthol-
ogous model of autosomal dominant polycystic kidney disease. Nat
Med 10:363–364, 2004
